Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taurus Medical was an Israeli medical device company focused on the development of advanced steerable catheter technologies for endovascular procedures. The company's primary innovation was a platform that allowed for precise navigation and placement of devices within the vascular system, addressing challenges in complex cardiovascular interventions. Founded as part of the Rainbow Medical portfolio, Taurus Medical aimed to improve the safety and efficacy of minimally invasive surgeries. The company's steerable technology provided interventionalists with greater control when navigating tortuous anatomy. In 2010, Taurus Medical was acquired by Medtronic for approximately $20 million to enhance their portfolio of endovascular and interventional cardiology tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taurus Medical.